About $300 million in cost savings is expected within two years of C.H. Robinson's RXO deal closing.
About $300 million in cost savings is expected within two years of C.H. Robinson's RXO deal closing. Stock Titan
Covered in this story
Call it yourself
No calls on $RXO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rxo Inc →Summary aggregated from Stock Titan's public RSS feed. The full reporting belongs to Stock Titan — please read it on their site.